SAN DIEGO, March 2, 2020 /PRNewswire/ -- NuVasive, Inc.
(NASDAQ: NUVA), the leader in spine technology innovation, focused
on transforming spine surgery with minimally disruptive,
procedurally integrated solutions, today announced it will
participate at Spine Summit 2020, the 36th Annual
Meeting of the Section on Disorders of the Spine and Peripheral
Nerves on March 5-8, 2020 at The
Cosmopolitan of Las Vegas.
"NuVasive will display key technologies at the Spine Summit that
enable our mission to transform surgery, advance care and change
lives for patients globally," said Matt
Link, president of NuVasive. "In addition, NuVasive will
host a workshop featuring world-renowned spine surgeons and the
Company's brand ambassador, Jerome
Bettis, who will educate on less invasive procedural
approaches."
NuVasive's booth #1021/1023 will feature several of its
latest technologies, including:
- X360™ system – Comprehensive approach to lateral
single-position surgery, which leverages advanced techniques and
technologies to deliver patient-specific care, while enhancing
operating room workflow and efficiency.
- Advanced Materials Science™ – Porous implant technologies
combining the inherent benefits of porosity with the advantageous
material properties of PEEK and titanium, designed for fusion.
- Pulse® platform– Integrated technology platform that includes
neuromonitoring, surgical planning, radiation reduction, imaging
and navigation functions, with extensible capabilities for robotics
and smart tools, designed to improve a surgeon's ability to utilize
minimally invasive surgical techniques.1
NuVasive will host a lunch workshop Less invasive anterior
and posterior procedural approaches presented by Drs.
Juan Uribe, chief of spinal
disorders and vice chairman of neurosurgery department at Barrow
Neurological Institute and Adam
Kanter, chief of spine and director of minimally invasive
spine program at University of
Pittsburgh Medical Center, and special guest, Jerome Bettis, XLIF®
patient and NuVasive's brand ambassador. The workshop will take
place on Friday, March 6 from
12:00-1:00 p.m. PST.
In addition, NuVasive will support the Spine Summit cadaveric
lab, with hands-on learning of innovative new technologies in
spine. NuVasive will highlight the X360 system with Drs.
Juan Uribe, and Julianne Santarosa, a leading access surgeon at
Dallas Surgical Specialists, during the cadaveric lab. The lab will
take place on Saturday, March 7 from
1:30-5:30 p.m. PST.
About NuVasive
NuVasive, Inc. (NASDAQ: NUVA)
is the leader in spine technology innovation, focused on
transforming surgery, advancing care, and changing lives through
less invasive, procedurally integrated solutions designed to
deliver reproducible and clinically-proven surgical outcomes. The
Company's procedural portfolio includes access instruments,
implantable hardware, biologics, software systems for surgical
planning, navigation and imaging solutions, magnetically adjustable
implant systems for spine and orthopedics, and intraoperative
monitoring service offerings. With more than $1 billion in revenue, NuVasive has approximately
2,800 employees and operates in more than 50 countries serving
surgeons, hospitals and patients. For more information, please
visit www.nuvasive.com.
Forward-Looking Statements
NuVasive cautions
you that statements included in this news release that are not a
description of historical facts are forward-looking statements that
involve risks, uncertainties, assumptions and other factors which,
if they do not materialize or prove correct, could cause NuVasive's
results to differ materially from historical results or those
expressed or implied by such forward-looking statements. The
potential risks and uncertainties which contribute to the uncertain
nature of these statements include, among others, risks associated
with acceptance of the Company's surgical products and procedures
by spine surgeons, development and acceptance of new products or
product enhancements, clinical and statistical verification of the
benefits achieved via the use of NuVasive's products (including the
iGA® platform), the Company's ability to effectually
manage inventory as it continues to release new products, its
ability to recruit and retain management and key personnel, and the
other risks and uncertainties described in NuVasive's news releases
and periodic filings with the Securities and Exchange Commission.
NuVasive's public filings with the Securities and Exchange
Commission are available at www.sec.gov. NuVasive assumes no
obligation to update any forward-looking statement to reflect
events or circumstances arising after the date on which it was
made.
1 Certain applications of the Pulse
platform are under development and not available for commercial
sale; robotics and smart tools are not cleared for use by
the FDA.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/nuvasive-to-participate-at-spine-summit-2020-301014124.html
SOURCE NuVasive, Inc.